연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1647. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles
Park DH, Jung BK, Lee YS, Jang JY, Kim MK, Lee JK, Park H, Seo J, Kim CW.
Gene Ther. 2015 Apr;22(4):325-32
Link
1646. Family-Based Association Study of Pulmonary Function in a Population in Northeast Asia.
Son HY1, Sohn SW2, Im SH3, Kim HJ4, Lee MK5, Gombojav B6, Kwon HS7, Park DS8, Kim HL9, Min KU10, Sung J5, Seo JS11, Kim JI12.
PLoS One. 2015 Oct 2;10(10):e0139716. doi: 10.1371/journal.pone.0139716. eCollection 2015.
Link
1645. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men.
Son KY1,2, Son HY3, Chae J4, Hwang J5, Jang S6, Yun JM7,8, Cho B9,10, Park JH11,12, Kim JI13,14,15,16.
Lipids Health Dis. 2015 Sep 13;14:105. doi: 10.1186/s12944-015-0111-5.
Link
1644. . Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: A multi-institutional study from the Korean Radiation Oncology Group.
CW Wee, W Sung, HCl Kang, KH Cho, TJ Han, BK Jeong, JU Jeong, H Kim, IA Kim, JH Kim, SH Kim, S Kim, DS Lee, MY Lee, DH Lim, HL Park, CO Suh, SM Yoon, IH Kim.
Radiat Oncol. 2015 Jul 2;10:137
Link
1643. Additional Survival Benefit of Involved-Lesion Radiation Therapy After R-CHOP Chemotherapy in Limited Stage Diffuse Large B-Cell Lymphoma.
Jeanny Kwon, Il Han Kim, Byoung Hyuck Kim, Tae Min Kim, Dae Seog Heo
Int J Radiat Oncol Biol Phys 2015 May 1, ;92(1);91-98
Link
1642. In vitro and In vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation.
Eui Kyu Chie, Jin Hee Shin, Jin Ho KIM, Hak Jae KIM, In Ah KIM, MD, Il Han KIM
Cancer Res Treat. 2015 Jul;47(3):527-33
Link
1641. Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy.
Kim JW1, Min CK2, Mun YC3, Park Y4, Kim BS4, Nam SH5, Koh Y6, Kwon JH7, Choe PG8, Park WB9, Kim I10.
J Clin Virol. 2015 Dec;73:64-9. doi: 10.1016/j.jcv.2015.10.018. Epub 2015 Oct 24.
Link
1640. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
Lee YG1,2, Lee E1, Kim I1, Lee KW3, Kim TM1, Lee SH1, Kim DW1, Heo DS1.
Cancer Res Treat. 2015 Oct;47(4):670-5. doi: 10.4143/crt.2014.045. Epub 2015 Jan 2.
Link
1639. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.
Suh KJ1, Kim I, Lim J, Ha H, Park S, Koh Y, Yoon SS, Park S.
Clin Transplant. 2015 Feb;29(2):124-33. doi: 10.1111/ctr.12492. Epub 2014 Dec 20.
Link
1638. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Suh KJ1, Keam B2, Kim M1, Park YS1, Kim TM3, Jeon YK4, Kim DW3, Chung DH4, Kim YW1, Heo DS3.
Clin Lung Cancer. 2015 Nov 30. pii: S1525-7304(15)00276-4. doi: 10.1016/j.cllc.2015.11.012. [Epub ahead of print]
Link